| G‐Quadruplexes act as sequence‐dependent protein chaperones A Begeman, A Son, TJ Litberg, TH Wroblewski, T Gehring, ... EMBO reports 21 (10), e49735, 2020 | 22 | 2020 |
| Cytokine-laden extracellular vesicles predict patient prognosis after cerebrovascular accident A Fringuello, PD Tatman, T Wroblewski, JA Thompson, X Yu, KO Lillehei, ... International Journal of Molecular Sciences 22 (15), 7847, 2021 | 7 | 2021 |
| High-throughput mechanistic screening of epigenetic compounds for the potential treatment of meningiomas PD Tatman, TH Wroblewski, AR Fringuello, SR Scherer, WB Foreman, ... Journal of Clinical Medicine 10 (14), 3150, 2021 | 7 | 2021 |
| Pharmacogenetic variation in Neanderthals and Denisovans and implications for human health and response to medications TH Wroblewski, KE Witt, S Lee, RS Malhi, D Peede, E Huerta-Sánchez, ... Genome biology and evolution 15 (12), evad222, 2023 | 1 | 2023 |
| Targeting DNA methyl transferases with decitabine in cultured meningiomas PD Tatman, TH Wroblewski, AR Fringuello, SR Scherer, WB Foreman, ... World Neurosurgery 162, e99-e119, 2022 | 1 | 2022 |
| HIGH-THROUGHPUT SCREENING OF FDA-APPROVED COMPOUNDS IN GLIOMA AND GLIOBLASTOMA IDENTIFIES NOVEL THERAPEUTICS T Wroblewski, P Tatman, A Fringuello, S Scherer, W Foreman, D Damek, ... Neuro-Oncology 23, 78-78, 2021 | 1 | 2021 |
| High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies HDAC, G9a, and Jumonji-Domain Inhibition as Potential Therapies PD Tatman, TH Wroblewski, AR Fringuello, SR Scherer, WB Foreman, ... Journal of Neurological Surgery Part B: Skull Base 84 (05), 452-462, 2023 | | 2023 |
| Pharmacogenetic variation in archaic and modern humans KE Witt, TH Wroblewski, SB Lee, RS Malhi, E Huerta-Sanchez, F Villanea, ... AMERICAN JOURNAL OF BIOLOGICAL ANTHROPOLOGY 177, 199-199, 2022 | | 2022 |
| High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies Sensitivities toward HDAC, G9A, and Jumonji Domain Inhibition P Tatman, T Wroblewski, A Fringurello, S Scherer, W Foreman, D Damek, ... Journal of Neurological Surgery Part B: Skull Base 83 (S 01), A155, 2022 | | 2022 |
| High-Throughput Screening of FDA-Approved Compounds, Validated with Three Separate Xenograft Models, Identifies Brigatinib as a Potential Treatment for Recurrent and Metastatic … PD Tatman, T Wroblewski, A Fringurello, S Scherer, W Foreman, ... Journal of Neurological Surgery Part B: Skull Base 83 (S 01), A033, 2022 | | 2022 |
| High-Throughput Screening of Meningiomas Identifies Proteasome Inhibition as a Potential Treatment Avenue TH Wroblewski, PD Tatman, AR Fringuello, SR Scherer, WB Foreman, ... Journal of Neurological Surgery Part B: Skull Base 83 (S 01), A044, 2022 | | 2022 |
| DNA Methyl Transferase Inhibition in Meningiomas TH Wroblewski, PD Tatman, AR Fringuello, SS Scherer, WB Foreman, ... Journal of Neurological Surgery Part B: Skull Base 83 (S 01), A040, 2022 | | 2022 |
| Archaic introgression and variation in pharmacogenes and implications for local adaptation TH Wroblewski, KE Witt, S Lee, RS Malhi, E Huerta-Sanchez, F Villanea, ... bioRxiv, 2021.11. 27.470071, 2021 | | 2021 |
| DDRE-10. SCREENING OF EPIGENETIC COMPOUNDS IN GLIOMA AND GLIOBLASTOMA IDENTIFIES NOVEL THERAPEUTICS FOR THEIR POTENTIAL TREATMENT P Tatman, T Wroblewski, A Fringuello, S Scherer, W Foreman, D Damek, ... Neuro-Oncology 23 (Supplement_6), vi76-vi76, 2021 | | 2021 |
| DDRE-43. SCREENING OF FDA-APPROVED COMPOUNDS FOR THE TREATMENT OF CHORDOMA, WITH IN VIVO VALIDATION USING THREE DIFFERENT XENOGRAFT MODELS, IDENTIFIES BRIGATINIB AS A POTENTIAL … P Tatman, T Wroblewski, A Fringuello, S Scherer, W Foreman, D Damek, ... Neuro-Oncology 23 (Suppl 6), vi83, 2021 | | 2021 |
| HIGH-THROUGHPUT SCREENING OF EPIGENETIC COMPOUNDS FOR THE TREATMENT OF CHORDOMA IDENTIFIES POTENTIAL NOVEL THERAPEUTICS T Wroblewski, P Tatman, A Fringuello, S Scherer, W Foreman, D Damek, ... NEURO-ONCOLOGY 23, 84-84, 2021 | | 2021 |
| Romidepsin Is a Possible Treatment for Meningiomas through Dual Inhibition of Classes 1 and 2 HDACS PD Tatman, A Fringuello, W Foreman, S Scherer, T Wroblewski, R Jensen, ... Journal of Neurological Surgery Part B: Skull Base 81 (S 01), A105, 2020 | | 2020 |
| High-Throughput Screening of Epigenetic Inhibitors in Chordoma and Chondrosarcoma W Foreman, PD Tatman, A Fringuello, T Wroblewski, S Scherer, R Jensen, ... Journal of Neurological Surgery Part B: Skull Base 81 (S 01), A133, 2020 | | 2020 |
| Inhibition of PDGFR May Be a Viable Treatment Option for Meningiomas T Wroblewski, PD Tatman, A Fringuello, W Foreman, S Scherer, D Damek, ... Journal of Neurological Surgery Part B: Skull Base 81 (S 01), A068, 2020 | | 2020 |
| DDIS-26. HIGH-THROUGHPUT DRUG SCREENING OF MENINGIOMAS IDENTIFIES HDAC INHIBITORS AS PROMISING TARGETS ACROSS GRADES P Tatman, A Fringuello, T Wroblewski, S Scherer, W Foreman, ... Neuro-Oncology 21 (Suppl 6), vi68, 2019 | | 2019 |
